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The rate of propagation of influenza virus in human adenocarcinoma Caco-2 cells was found to negatively correlate with the concentration
of fetal bovine serum (FBS) in the culture medium. Virus replicated more rapidly at lower FBS concentrations (0 or 2%) than at higher
concentrations (10 or 20%) during an early stage of infection. Basal and interferon (IFN)-induced levels of typical IFN-inducible anti-viral
proteins, such as 2V,5V-oligoadenylate synthetase, dsRNA-activated protein kinase and MxA, were unaffected by variation in FBS
concentrations. But promyelocytic leukemia protein (PML) was expressed in a serum-dependent manner. In particular, the 65 to 70 kDa
isoform of PML was markedly upregulated following the addition of serum. In contrast, other isoforms were induced by IFN treatment, and
weakly induced by FBS concentrations. Immunofluorescence microscopy indicated that PML was mainly formed nuclear bodies in Caco-2
cells at various FBS concentrations, and the levels of the PML-nuclear bodies were upregulated by FBS. Overexpression of PML isoform
consisting of 560 or 633 amino acid residues by transfection of expression plasmid results in significantly delayed viral replication rate in
Caco-2 cells. On the other hand, downregulation of PML expression by RNAi enhanced viral replication. These results indicate that PML
isoforms which are expressed in a serum-dependent manner suppress the propagation of influenza virus at an early stage of infection.
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Host cells counteract viral infection in various ways,
including mechanisms that involve 2V,5V-oligoadenylate
synthetase (2–5AS)/RNase L system, dsRNA-activated
protein kinase (PKR) the Mx family proteins and so on
(Alcami and Koszinowski, 2000; Garcia-Sastre, 2001;
Goodbourn et al., 2000; Gotoh et al., 2002). Many of these
intrinsic anti-viral factors are induced by interferon (IFN).
An IFN-induced factor, the promyelocytic leukemia (PML)
protein (Lavau et al., 1995; Stadler et al., 1995; Chelbi-Alix0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.08.010
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E-mail address: fujii@sapmed.ac.jp (N. Fujii).et al., 1998), also contributes to anti-viral activity, as has
been shown for the replication of vesicular somatitis virus
(VSV), influenza virus and human foamy virus (Chelbi-Alix
et al., 1998; Everett, 2001; Regad and Chelbi-Alix, 2001),
but not encephalomyocarditis virus (Chelbi-Alix et al.,
1998). On the other hand, it has been reported that some
viruses disrupt organization PML and counteract its function
to efficient virus replication. Adenovirus IX protein disrupts
PML nuclear body organization and then sequestrates PML
into clear amorphous inclusions (Rosa-Calatrava et al.,
2003). Herpes simplex virus type 1 immediate early protein
ICP0 mediates degradation of PML (Chelbi-Alix and de
The, 1999; Everett et al., 1998; Gu and Roizman, 2003).
PML was originally identified as a fusion protein with
retinoic acid receptor alpha (RAR-a) formed by the t(15;17)05) 106 – 115
Fig. 1. Propagation rates of influenza virus in Caco-2 cells cultured in
medium containing various concentrations of FBS in the absence (A) or
presence of IFN-a (B). (A) Caco-2 cells were cultured in medium
containing 0, 2, 10 or 20% (v/v) FBS for 24 h. Cells were washed with
PBS(), and infected with influenza virus at MOI 0.1. One hour after
infection, cells were washed with PBS() and then cultured in medium
containing FBS at initial concentration. Culture supernatants were collected
at various times indicated. Virus titers were determined by a plaque forming
assay using Caco-2 cells as indicator cells and were expressed as plaque
forming units (pfu) per milliliter. The experiments were at least three times,
the virus titer was expressed as mean value T SD. (B) Caco-2 cells were
cultured in the presence of 1000 IU/ml IFN-a for 24 h before and after
infection with influenza virus. Unless otherwise mentioned, the experiment
was performed as in panel A.
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locytic leukemia (APL) (Warrell et al., 1993). PML is
shown to concentrate in speckled subnuclear structures
referred to as PML nuclear bodies (PML-NBs), ND10 or
PML oncogenic domains (POD) (Maul et al., 2000). More
than 30 proteins have been identified to colocalize with the
PML protein in PML-NBs either transiently or constitu-
tively. PML-NBs regulate cellular proliferation, apoptosis
and senescence though controlling the assembly and
function of various transcription factors (Ferbeyre et al.,
2000; Guo et al., 2000; Le et al., 1998; Quignon et al., 1998;
Wang et al., 1998). For example, PML controls the targeting
of p53 into the PML-NB, its acetylation and transcriptional
activation. Consequently, the p53 target genes that contrib-
ute to apoptosis and senescence, such as BAX and p21, are
transcribed (Guo et al., 2000). However, the PML protein
contributes to anti-viral activity, but it is not known how it
inhibits viral replication. It is thought that PML indirectly
inhibits viral propagation by modifying other cellular
proteins that modulate viral replication (Regad and
Chelbi-Alix, 2001).
In this study, we describe a serum concentration-depend-
ent suppression of influenza virus replication in Caco-2
cells. We propose that this anti-viral activity is caused by
PML, which is expressed in a serum-dependent manner.Results
Rate of influenza virus propagation negatively correlates
with the concentration of serum in the culture medium
Caco-2 cells were used for infection experiments of
influenza virus. Unlike other permissive cell lines such as
MDCK and Vero cells, Caco-2 cells do not require non-
serum condition and the addition of trypsin for infection
with influenza virus. Because Caco-2 cells possess an
endogenous trypsin-like protease that cleaves influenza
virus hemagglutinin (HA) (Zhirnov and Klenk, 2003). The
cleavage of HA is an essential step in the infection to host
cell.
We found that the rates of propagation of influenza virus
in Caco-2 cells vary under different cell culture conditions.
To examine this effect further, we infected Caco-2 cells
cultured in various concentrations of fetal bovine serum
(FBS) with influenza virus (Fig. 1A). Virus propagated
more rapidly under no or low concentration serum (0 or 2%)
compared to under higher serum concentration (10 and
20%). This indicates that serum in culture medium inhibits
virus proliferation rate in a concentration-dependent manner.
Caco-2 was highly sensitive to IFN as determined by
suppression of VSV replication. The IFN-induced anti-VSV
activity was comparable to Vero cells (data not shown).
IFN-a treatment prior to influenza virus infection also
suppressed viral replication, but the anti-viral activity was
relatively weak against influenza virus. However, IFN-induced anti-viral effect against influenza virus was clearly
observed under condition of higher FBS concentration (10%
or 20%), but was not observed a significant anti-viral effect
under lower FBS concentration (0 or 2%) (Fig. 1B). These
results suggest that serum induces anti-viral factor(s) that
inhibit the early phases of viral propagation. This serum
concentration-dependent anti-viral activity was not less than
IFN-inducible anti-viral activity in Caco-2 cells.
Expression of PML protein depends on serum
concentrations
To address factor(s) contributing to the serum-depend-
ent anti-viral effect, we examined the expression levels of
known anti-viral factors in culture media with various
concentrations of FBS. Protein and mRNA levels were
determined by Western blotting analysis and semi-
quantitative reverse transcription-polymerase chain reac-
tion (RT-PCR), respectively (Figs. 2 and 3). The basal
and IFN-a-induced expression levels of PKR, MxA and
2–5AS were not affected by FBS concentration. These
results suggest that the expression of these major IFN-
inducible anti-viral factors is not influenced by serum
concentration. On the other hand, the protein expression
levels of PML were dramatically influenced by FBS
concentration. In Western blotting analysis, the 65 to 70
kDa population of PML proteins was notably increased in
a serum concentration-dependent manner (Fig. 2). Other
populations, 95 to 100 kDa and 80 to 85 kDa, were also
more highly expressed at higher serum concentrations but
to a lesser extent compared with the 65 to 70 kDa
Fig. 2. Effect of serum concentration on protein expression levels of PML and other IFN-inducible gene products. Caco-2 cells were cultured for 24 h in
medium containing 0, 2, 10 or 20% (v/v) FBS in the absence or presence of IFN-a at 1000 IU/ml. Cell lysates were prepared and assessed by Western blot
analysis. Actin was examined as a control. The band indicated by an arrow with asterisk is considered to be non-specific. The experiments were at least three
times.
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complexity of the PML bands. The complexity was
caused by both/either various isoforms of PML proteins
and/or non-specific bands of this antibody. So we
confirmed the specificity of the anti-PML antibody using
individually expressed recombinant proteins of PML
isoforms by in vitro translation. Each isoform expressed
one main single band as detected by anti-FLAG antibody
(Fig. 4, right panel). The bands detected by anti-FLAG
antibody are consistent with the bands stained by theFig. 3. Effect of serum concentration on the expression of IFN-inducible
genes at mRNA levels determined by semi-quantitative RT-PCR. Caco-2
cells were cultured for 24 h in medium containing 0, 2, 10 or 20% (v/v)
FBS in the absence or presence of IFN-a at 1000 IU/ml. Total cellular RNA
was isolated and subjected to RT-PCR. GAPDH was examined as a control.
The experiments were at least three times.anti-PML antibody (Fig. 4, left panel). The result
indicates that the rabbit anti-PML antibody possesses
sufficient sensitivity and specificity for the detection of
PML isoforms in Western blotting. Identification of
isoforms was deduced from the mobility of recombinant
PML protein of each isoform, which is prepared by in
vitro translation. The IFN-inducible 95 to 100 kDa
isoforms that we observed seem to be PML I and II
and the 80 to 85 kDa isoforms appear to correspond to
PML III to V. The 65 to 70 kDa isoform of PML, which
is markedly influenced by serum concentration, was
attributable to PML VI. The expression levels of all
isoforms of PML were markedly decreased by serum
starvation, and restored by culturing cells in serum-
containing medium (Fig. 5). Among these, 65 to 70 kDa
population of PML was most markedly increased by the
addition of serum. In this serum starvation/restoration
experiment, the mRNA levels of PKR, 2–5AS and
GAPDH did not change, whereas the decreased levelsFig. 4. Expression and Western blot analysis of standard recombinant
proteins of PML isoforms (I to VI). Expression plasmids carrying FLAG
epitope-tagged PML isoforms (I to VI) were mixed with in vitro
transcription/translation rabbit reticulocyte lysate system, and then incu-
bated. The resulting materials were analyzed with Western blotting using
anti-PML antibody and anti-FLAG antibody.
Fig. 5. Expression levels of PML under conditions of serum starvation and restoration. Caco-2 cells were cultured in serum-free medium for 36 h. And then,
FBS was added to the cells at a concentration of 10% (v/v) FBS and cultured. The cells were harvested at various time points indicated. (A) Protein levels were
determined by Western blot analysis. Actin and h-tubulin were examined as a control. A band indicated by an arrow with asterisk is considered to be non-
specific. (B) mRNA levels were determined by RT-PCR. GAPDH was examined as a control. The experiments were at least three times.
Fig. 6. Effect of serum concentration on protein expression levels of PML
in Vero and MDCK cells. Vero and MDCK cells were cultured for 24 h in
medium containing 0, 2, 10 or 20% (v/v) FBS. Cell lysates were prepared
and assessed by Western blot analysis. Actin was examined as a control for
protein loading. The experiments were at least three times.
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starvation returned to control levels following the
restoration of serum (Fig. 5). Since PML has been
reported to be an IFN-inducible proteins (Stadler et al.,
1995), we analyzed PML proteins in Caco-2 cells after
IFN-a treatment by Western blot analysis (Fig. 2). The
levels of the 95 to 100 kDa isoforms and the 80 to 85
kDa isoforms of PML were increased by IFN-a treat-
ment, but the 65 to 70 kDa population was almost
unchanged. These results indicate that the expression of
the 65 to 70 kDa PML isoforms is mainly regulated by
serum, whereas the 95 to 100 kDa and 80 to 85 kDa
isoforms are regulated mainly by IFN-a and relatively
weakly by serum. Consistent with this interpretation, cells
cultured in medium containing higher concentrations of
FBS expressed higher levels of PML mRNA (Fig. 3). On
the other hand, PML mRNA was also slightly upregulated
by IFN-a treatment, in contrast to that other cells strongly
induce PML by IFN-a (Lavau et al., 1995; Stadler et al.,
1995; Chelbi-Alix et al., 1998). Serum-induced and IFN-
a-induced expression appears to make similar contribu-
tions to the expression levels of the overall isoforms of
PML. Serum-dependent PML expression was also
observed in other cell lines, such as Vero and MDCK.
But the degree of serum-dependent changes in these cells
was less than that in Caco-2 cells, and isoform-specific
expression patterns were not clearly observed (Fig. 6).
Viral replication rates in MDCK and Vero cells were
more rapid in lower serum concentration than in higher
serum concentration similar to Caco-2 cells; however, the
dependency on serum concentration was relatively less
compared with Caco-2 cells (data not shown).
Fluorescence microscopy analysis was carried out with a
mouse monoclonal anti-PML antibody, which reacts with allPML isoforms. PML proteins, most of which formed
nuclear bodies and a little population of which located in
cytosol, were markedly upregulated with increasing con-
centration of serum (Fig. 7). The level of PML-NBs was
slightly upregulated by treatment with IFN-a compared with
variations of serum concentrations. These observations are
consistent with the results of Western blot analysis and RT-
PCR (Figs. 2 and 3).
PML inhibits the propagation of influenza virus
We examined the effect of overexpression of two
isoforms of PML [PML IV, consisting of 633 amino acid
residues (aa) and PML VI, 560 aa] by transfection of
Fig. 7. Effect of serum concentration on nuclear bodies containing PML as determined by immunofluorescence microscopy. Caco-2 cells were cultured in
medium containing 0, 2, 10 or 20% (v/v) FBS in the absence or presence of IFN-a (1000 IU/ml) for 36 h. The cells were fixed and stained by an anti-PML
antibody and then an Alexa Fluor 594-labeled secondary antibody (red). Nuclei were counter-stained with DAPI (blue). Phase: phase contrast observation. The
experiments were at least three times.
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that was strongly upregulated in a serum-dependent manner
in Caco-2 cells was likely to be PML VI (560 aa). Because
transfected PML VI migrated with a mobility similar to that
of PML (65 to 70 kDa) in Western blot analysis (Fig. 8B).
The mobility of transfected PML VI seemed to be slightly
lower than that of endogenous serum-dependent PML,
because the transfected PML VI carries V5-tag consisting
of 14 aa. Forty-eight hours after transfection, the cells were
infected with influenza virus. MOI used in the transfection
experiments was lower (0.001) than that used in experi-
ments with untransfected Caco-2 (MOI 0.1). The virus
propagates too rapid in cells treated with transfection
reagent. The morphology of Caco-2 cells was altered to
be relatively depressed by treatment of the transfection
reagent compared with intact cells (data not shown). Thus,
the efficacy of infection seemed to increase in the trans-
fected cells. Cells overexpressing PML showed a significant
reduction (approximately 2 log reduction at 24 h after
infection) in the rate of viral propagation compared with
control cells transfected with mock plasmid (Fig. 8A).
Overexpression of another isoform PML IV also suppressed
viral propagation. PML IV appears to correspond to one of
the 80 to 85 kDa isoforms. These results suggest that PMLproteins are serum-dependent factors that suppress the
propagation rate of influenza virus.
RNA interference (RNAi) silencing of PML enhances
influenza virus replication
To reveal the role of PML on influenza virus replication,
we tried to downregulate PML expression by short
interfering RNA (siRNA). Expression plasmid coding
siRNA specific for PML was transfected into Caco-2 cells.
After 48 h transfection, influenza virus was challenged.
MOI used in this experiment was 0.01, and it is lower than
that used in experiments with untransfected Caco-2 (MOI
0.1). The efficacy of infection seemed to increase in the
transfected cells, because the morphology of cells was
altered to be depressed by transfection reagent as described
above. The siRNA to PML successfully reduced PML
mRNA expression and protein expression of all PML
isoforms (Figs. 9A and B), whereas control siRNA did
not affect PML mRNA levels as compared to intact Caco-2
cells. When cells were cultured in medium containing 10%
FBS, infected influenza virus more rapidly propagated in the
cells by expression of siRNA to PML than control siRNA
(Fig. 9C). The enhancement of virus propagation by siRNA
Fig. 8. Effect of exogenous expression of PML isoforms (PML IVand PML
VI) on the propagation of influenza virus in Caco-2 cells. An expression
plasmid carrying PML cDNA (PML IVor VI) or empty plasmid (for control
experiment; mock) was transfected into Caco-2 cells cultured in medium
containing 2% (v/v) FBS. (A) Forty-eight hours after transfection, the cells
were infected with influenza virus at MOI 0.001. The supernatants were
collected at various times after infection. Virus titer in the supernatant was
determined. The experiments were at least three times, the virus titer was
expressed as mean value T SD. (B) Expression of PML. Cells were
harvested 48 h after transfection and lysed. The cell lysate was subjected to
Western blot analysis with an anti-PML antibody (PML) and an anti-V5 tag
antibody (V5). Actin was examined as a control. Arrows indicate positions
of PML IV (633 aa; upper arrow) and PML VI (560 aa; lower arrow). A
band indicated by the asterisk is considered to be non-specific.
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infection, cultured in medium containing 2% FBS, but the
extent of enhancement was very small. The enhanced viral
propagation by expression of siRNA was comparable to
viral propagation in cells cultured in serum-free medium
without regard to serum concentration in culture medium
(Fig. 1). These results suggest that PML is necessary for
serum-dependent anti-viral activity in Caco-2 cells.Discussion
In the present study, we showed that the concentration of
serum in culture medium negatively correlates with the rate
of influenza virus propagation in Caco-2 cells. The growth
of Caco-2 cells and the extent of the serum-dependent anti-
viral activity quite differed with respect to the basal
medium, and FBS manufacturer and lot number. We
hypothesized that nutrients such as vitamins and/or growth
factors in FBS are essential for cell growth and anti-viral
status of Caco-2 cells. So we investigated this novel serum-
dependent host regulatory factor. The basal and IFN-
induced levels of typical anti-viral factors such as MxA,
2–5AS and PKR were not affected by serum concentration.
It suggests that they do not contribute to the serum-
dependent anti-viral effect. In contrast, the levels of PMLwere dramatically influenced by serum concentration in
Caco-2 cells. Other cell lines, such as Vero and MDCK, also
showed serum-dependent PML expression and suppression
of viral replication, but the degree of change was relatively
smaller than Caco-2 cells. This is probably caused by that
Caco-2 was highly auxotrophic, namely sensitive to serum
concentration, as compared to other cell lines. PML is
thought to be an organizing protein of nuclear body and
contributes to numerous cellular functions, such as growth
suppression, apoptosis and senescence (Salomoni and
Pandolfi, 2002). PML is induced by IFN and has been
shown to be an anti-viral factor (Everett, 2001; Regad and
Chelbi-Alix, 2001); however, anti-viral activity of PML is
less powerful than that of MxA in case of influenza virus
(Chelbi-Alix et al., 1998). In contrast, we observed that the
serum-dependent anti-viral activity of Caco-2 cells was
additive and comparable to IFN-induced anti-viral activity
(Fig. 1).
We observed at least three major populations of PML in
Caco-2 cells by Western blot analysis. One of these was a
65 to 70 kDa isoform (PML VI). Expression of this lower
molecular weight isoform was mainly in serum concen-
tration-dependent manner in Caco-2 cells. Others were 95
to 100 kDa isoforms (PML I and II) and 80 to 85 kDa
isoforms (PML III to V). The higher molecular weight
isoforms were mainly upregulated by IFN-a in Caco-2
cells. However, their expression was affected to a lesser
extent by serum concentration compared with the 65 to 70
kDa isoform. The PML gene consists of nine exons.
Alternatively, spliced isoforms, which are divided into
seven groups as suggested by Jensen et al. (2001), are
formed by the truncation of 3V-side of exons, namely C-
terminal region of the PML protein. Isoforms I to VI
commonly contain exons 1 to 6. Chelbi-Alix et al. (1998)
reported that overexpression of PML III confers resistance
against influenza virus and VSV. We observed that total
PML mRNA was expressed in both serum-dependent and
IFN-dependent manner. Our observation suggests that the
65 to 70 kDa isoform (PML VI) is specifically serum-
dependent and that other isoforms (PML I–V) are IFN- and
serum-dependent.
Furthermore, transfection of a PML VI plasmid resulted
in the suppression of influenza virus replication in the early
infection phase. We also found that another isoform PML
IV, whose expression was controlled by both IFN-a and
serum, also shared suppressive ability to propagation of
influenza virus at a similar level of PML VI. However, the
exogenously supplied PML showed relatively weak anti-
viral activity compared to serum-induced anti-viral activity.
The reason is still unclear. It may be caused by that other
serum-dependent factor(s) exist or different isoforms of
PML cooperate for maximal anti-viral activity. On the other
hand, downregulation of all isoforms of PML by RNAi
resulted in that viral propagation is enhanced (Fig. 9) as
comparable to a similar level of viral propagation cells
cultured in serum-free medium (Fig. 1). This suggests that
Fig. 9. Effect of downregulation of PML by RNAi on the propagation of influenza virus in Caco-2 cells. An expression plasmid carrying siRNA specific for all
isoforms of PML (pU6-PMLi) or control plasmid (pU6-Ctli) was transfected into Caco-2 cells. (A and B) Expression of PML. The cells transfected with pU6-
PMLi or pU6-Ctli and intact cells were cultured in MEM containing various concentrations of FBS for 48 h. The cells were harvested and total mRNA was
extracted. Intact cells cultured in medium containing 0, 2, 10% (v/v) FBS were used as a control. (A) The mRNA expression of PML (all isoforms) was
determined by semi-quantitative RT-PCR. GAPDH was determined as a control. (B) The protein expression of PML was determined by Western blotting. Actin
was used as a control. (C) Forty-eight hours after transfection, the cells were infected with influenza virus at MOI 0.01. And then the cells were cultured in
MEM containing 2% (v/v) FBS. The supernatants were collected at various times after infection. Virus titer in the supernatant was determined. The experiments
were at least three times, the virus titer was expressed as mean value T SD.
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activity in Caco-2 cells.
Most serum-induced PML formed nuclear bodies and
only a little population localized in the cytosol (Fig. 7). This
distribution did not obviously change by serum concen-
tration nor IFN-a treatment. Anti-viral activity of PML
seemed not to be attributable to the organization of PML in
cells. However, we have not examined a change of
molecules associated with the PML-NBs under different
serum concentrations. This issue remains to be investigated.
The serum-dependent expression of PML has not been
previously reported. Matsuzaki et al. (2003) reported that
PML-NBs’ formation increases shortly after serum stim-
ulation. The interaction of serum response factor (SRF) and
CBP acetyltransferase occurs in the PML-NBs. The PML-
NBs modulate SRF-dependent transcription of immediate
early genes such as c-fos. This is an evidence for
correlation of PML function with serum. However, mech-
anism of serum-dependent expression has still been
obscure. The specific increase in the 65 to 70 kDa PML
isoform (PMLVI) induced by serum should be regulated
post-transcriptionally (by alternative splicing), but not in
the transcriptional level. The expresion patterns of PMLVI
were different from those of other PML isoforms, namely
PMLVI expression was not changed by IFN treatment.
Serum- or cell growth-dependent alternative splicing
mechanism on PML mRNA in Caco-2 cells was suggested.
But further studies need to clarify this alternative splicing.We have noted a novel serum-dependent anti-viral effect
in Caco-2 cells, which is more potent than the IFN-induced
effect. Furthermore, the serum-dependent and IFN-induced
anti-viral activities are additive. PML, whose expression
largely depends on cellular conditions such as nutrition and
growth factors, may be part of an initial innate defense
response prior to the IFN system during the acute infection
phase of influenza virus.Materials and methods
Cell lines, viruses and reagents
Human colorectal adenocarcinoma Caco-2 cells, Madin–
Darby canine kidney (MDCK) cells and Vero cells were
obtained from the American Type Culture Collection
(Manassas, VA). Unless otherwise mentioned, Caco-2 cells
were routinely cultured in Minimum Essential Medium
(MEM; Gibco-Invitrogen, Carlsbad, CA) containing 10%
(v/v) FBS (Gibco-Invitrogen) in 25 cm2 plastic flask (Nunc,
Roskilde, Denmark) at 37 -C in 5% CO2. A clinical strain of
influenza virus [A/Hokkaido/92/99(H3)] was isolated from
a patient in Hokkaido Prefecture, Japan. Virus titers were
determined by a plaque formation assay using Caco-2 cells
as indicator cells. The Caco-2 cells were cultured in MEM
containing 2% FBS. Recombinant human IFN-a was
purchased from Serotech (Oxford, UK).
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were prepared by in vitro translation. Expression plasmids
for FLAG epitope-tagged PML isoforms I–VI (Beech et al.,
2005) were kindly provided by Dr. Keith N. Leppard
(University of Warwick, Coventry, UK). In vitro tran-
scription/translation of the expression plasmids was per-
formed by using TNT T7 coupled reticulocyte lysate system
(Promega, Madison, WI). After incubation, the resulting
lysate was analyzed by Western blotting using rabbit anti-
PML antibody (Santa Cruz, Santa Cruz, CA) and mouse
anti-FLAG monoclonal antibody (Sigma, St. Louis, MO).
Effect of serum concentration on virus replication
Caco-2 cells were inoculated into culture flasks at 1 
105 cells/ml and pre-cultured in MEM containing 10% (v/v)
FBS for 48 h. And then, the cells were cultured in medium
containing 0, 2, 10 or 20% (v/v) FBS for 24 h. After
washing cells with PBS(), cells were infected with
influenza virus at a multiplicity of infection of (MOI) 0.1
in a serum-free medium. After 1 h infection, the serum-free
medium containing residual virus was removed and then the
cells were cultured in a medium containing FBS at the same
concentration used for pre-culture. In some experiments,
IFN-a (1000 IU/ml) was included 24 h before and after
virus infection.
Serum starvation and restoration
Caco-2 cells were inoculated into culture flasks at 1 
105 cells/ml and pre-cultured in MEM containing 10% (v/v)
FBS for 48 h. And then, the cells were starved in a serum-
free medium for 36 h, and returned to a medium containing
10% (v/v) FBS. Cells were harvested at various times for
analysis.
Western blotting
Rabbit anti-PML antibody was purchased from Santa
Cruz. Mouse anti-p68 PKR, anti-actin and anti-h-tubulin
monoclonal antibodies were purchased from BD Bioscien-
ces Pharmingen (Franklin Lakes, NJ), Chemicon (Temecula,
CA) and Cedarlane (Ontario, Canada), respectively. Rabbit
anti-V5 tag antibody was purchased from Invitrogen.
Detailed methods for preparation of mouse anti-MxA
monoclonal antibodies will be described elsewhere. Briefly,
recombinant MxA protein encoded on pET3a-MxA was
expressed in Escherichia coli. MxA recovered in an
insoluble fraction was purified by extensive washes with 6
M urea. The final insoluble fraction was dissolved in an
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) sam-
ple buffer and subjected to an SDS-PAGE. A protein band
corresponding to MxA was excised, and MxA was eluted
from the gel piece. MxA thus purified was used for
immunization of mice (Balb/c). Preparation and selection
of monoclonal cell lines were carried out essentially asdescribed (Nagata et al., 1998). Four monoclonal cell lines
(KM1124; IgG1, KM1126; IgG1, KM1132; IgG2a and
KM1135; IgG1) producing antibodies against MxA were
established. These antibodies are used for measurement of
MxA (Turan et al., 2004; Yoshimasu et al., 2003).
For preparation of cell lysates, cells were suspended in
1% (v/v) Nonidet P-40, 120 mM NaCl, 1 mM dithiothreitol,
10% (v/v) glycerol, 5 mM EDTA, 1 mM phenylmethylsul-
fonyl fluoride, 1 mM Na3VO4, 1 mM NaF and 10 mM
HEPES-NaOH (pH 7.5), and kept on ice for 10 min. The
lysates were centrifuged at 10,000g for 10 min at 4 -C.
The supernatants were recovered, and the protein concen-
tration was determined by the method of Bradford (Brad-
ford, 1976). SDS-PAGE and Western blotting were carried
out as previously described (Yokota et al., 1999, 2001).
Alkaline phosphatase-conjugated anti-rabbit or mouse
immunoglobulin antibodies (BioSource, Camarillo, CA)
were used as secondary antibodies, and bromochloroindo-
lylphosphate/Nitro blue tetrazolium was used as an enzyme
substrate for detecting specific binding. The resulting bands
were scanned with a flatbed scanner and analyzed using the
public domain NIH Image program (available at http://
rsb.info.nih.gov/nih-image/) (US National Institutes of
Health, Bethesda, MD).
Immunofluorescence microscopic analysis
Mouse anti-PML monoclonal antibody (1B9) was
purchased from MBL (Nagoya, Japan). Alexa Fluor 594-
labeled goat anti-mouse IgG (H + L) (Molecular Probes,
Eugene, OR) was used as a secondary antibody. The
antibodies were diluted in PBS containing 0.1% BSA at
1:400 and 1:1000, respectively. Cells were fixed with
acetone at 20 -C for 20 min. Fixed cells were sub-
sequently incubated with the anti-PML antibody and the
Alexa Fluor 594-labeled secondary antibody at 37 -C for 1 h
each. The staining of a series of specimens was carried out
simultaneously. Nuclei were stained with 4V,6-diamidino-2-
phenylindole, dihydrochloride (DAPI). Fluorescence micro-
scopy was carried out with an Olympus IX71 system
(Olympus, Tokyo, Japan). The image capture conditions
were set at non-saturating condition and the images were
taken and processed at the same time and under the same
conditions.
Semi-quantitative reverse transcription-polymerase chain
reaction (RT-PCR)
Total RNA was prepared from cells with the RNeasy
Mini kit (Qiagen, Hiden, Germany). RT-PCR was carried
out with the OneStep RT-PCR kit (Qiagen) according to the
manufacture’s instruction. Amplified products were
resolved by 2% (w/v) agarose gel electrophoresis, and the
gel was stained by ethydium bromide. Quantitativity of the
experimental result was confirmed by linearity of determi-
nation curve with various amounts of RNA. The following
S. Iki et al. / Virology 343 (2005) 106–115114primer sets were used for the detection of each mRNA. The
primer set for detecting PML mRNA was sense; 5V-
GGCCGACTTCTGGTGCTTTGA-3V and antisense; 5V-
GGGCTGGCTTTCTTGGATACA-3V. The PML primer set
was detected for all types of PML isoforms. The primer set
for detection of mRNAs encoding 2–5AS mRNA was
sense; 5V-CCAGGAAATTAGGAGACAGC-3V and anti-
sense; 5V-TGGCAGGGAGGAAGCAGGAG-3V. The primer
sets for detecting MxA, PKR and glyceraldehyde-3-phos-
phodehydrogenase (GAPDH) mRNA were described pre-
viously (Fujii et al., 1999; Yokosawa et al., 1998; Yokota et
al., 2003).
Transient expression of PML
PML expression plasmids (pCDNA/ampSV5-PML560
and pCDNA/ampSV5-PML633) were kindly donated by
Drs Daniel Bailey and Peter O’Hare (Marie Curie Research
Institute, Surrey, UK) (Boutell et al., 2003). The plasmids
encode an isoform consisting of 560 amino acid residues
(corresponding to PML VI) and an isoform consisting of
633 amino acid residues (corresponding to PML IV),
respectively. Empty plasmid (pCDNA/ampSV5) was used
for experimental control (mock). Plasmids were transfected
into Caco-2 cells cultured in MEM containing 2% (v/v) FBS
using Superfect reagent (Qiagen) according to the manu-
facture’s instruction. Using these conditions, transfection
efficacies above 75% were consistently obtained as deter-
mined by transfection experiments by using green fluo-
rescence protein expression plasmid (data not shown).
Forty-eight hours after transfection, cells were infected with
influenza virus at MOI 0.001 in serum-free MEM. One hour
after infection, the medium was replaced with MEM
containing 2% FBS and cultured. Virus titer of the culture
supernatants was determined as above.
Expression of siRNA specific for PML
Target sequence for siRNA to all isoforms of the PML
used was according to a published data (5V-GAGUCGGCC-
GACUUCUGGU-3V), which corresponds in nucleotide
sequence to positions 334 to 352 of the PML coding region
relative to the first nucleotide of the start codon (Bruno et
al., 2003). Double-stranded oligo DNA coding siRNA of the
PML (3V-GAGTTGGCTGGCTTCTGGTGCGTGTGCTGT-
CCACCAGAAGTCGGCCGACTCTTTTT-5V) was synthe-
sized. The oligonucleotide was inserted into BspM1-
digested piGENE hU6 vector (BD Biosciences Clontech,
Tokyo, Japan). The plasmid was referred as pU6-PMLi. The
unrelated control plasmid (pU6-Ctli) was a kind gift from
Dr. Shoji Yamaoka (Tokyo Medical and Dental University,
Tokyo, Japan) (Saitoh et al., 2005). Plasmids were trans-
fected into Caco-2 cells cultured in MEM containing 2 or
10% (v/v) FBS using Superfect reagent. Forty-eight hours
after transfection, cells were infected with influenza virus at
MOI 0.01 in serum-free MEM. One hour after infection, themedium was replaced with MEM containing 2 or 10% (v/v)
FBS and cultured. Virus titer of the culture supernatants was
determined as above.Acknowledgments
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